Center for Neurotechnology
The Center for Neurotechnology is a non-profit NSF Engineering Research Center at the University of Washington, with MIT and SDSU as core partners, that develops neural devices and methods for engineered neuroplasticity in the brain and spinal cord and trains neural engineers from K-12 through graduate level.
- Company typePrivate
- Founded2011
- HeadquartersSeattle, United States
- Headcount51–100
- GTM typeB2B
- OfferingServices
What Center for Neurotechnology does
The Center for Neurotechnology (CNT) is a non-profit NSF Engineering Research Center founded in 2011 and headquartered at the University of Washington in Seattle, with core partners at the Massachusetts Institute of Technology and San Diego State University. The center conducts interdisciplinary neural engineering research across four thrust areas — Experimental Neuroscience, Computational Neuroscience, Communication and Interface, and Neuroethics — developing neural devices and methods for directing engineered neuroplasticity in the brain and spinal cord. Core technical capabilities include optogenetic neurophysiology platforms, bidirectional brain-computer interfaces, intracortical microstimulation, transcutaneous spinal cord stimulation, electrocorticographic decoding using 3D convolutional neural networks with explainable AI, and mathematical/computational modeling of cortical function. CNT's research output has included FDA market authorization (in 2024) for ONWARD's ARC-EX transcutaneous spinal cord stimulation system, based on research from co-director Chet Moritz's lab.
CNT does not sell commercial products; instead, its revenue model is structured around NSF Engineering Research Center funding and individual NSF research grants (e.g., a three-year 2025 SHF grant to Amir Alimohammad on ubiquitous BCIs), foundation grants such as those from the Dana Foundation, a formal industry membership program, and technology licensing to industry partners including ONWARD and Panaxium Research. The center operates an extensive education pipeline spanning K-12 outreach (Young Scholars Program-REACH, Research Experience for Teachers, neuroscience-for-neurodiverse-learners initiatives, school visits), undergraduate Research Experience for Undergraduates and a Minor in Neural Computation and Engineering, a Graduate Certificate in Neural Computation and Engineering, neuroengineering courses, veteran-focused programs, and student-run outlets such as the CNT BrainTech Journal and the Best Student Paper Award. Distribution of research occurs through peer-reviewed publications in high-impact journals (Nature Neuroscience, Science, Brain Stimulation, IEEE Transactions), conference presentations (Society for Neuroscience, COSYNE), technology transfer/licensing to industry, and open educational resources shared with K-12 teachers.
Center for Neurotechnology firmographics
Firmographics- Name
- Center for Neurotechnology
- Legal name
- Center for Neurotechnology
- Website
- https://centerforneurotech.uw.edu
- Company type
- Private
- Founded year
- 2011
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- The Center for Neurotechnology is a non-profit NSF Engineering Research Center at the University of Washington, with MIT and SDSU as core partners, that develops neural devices and methods for engineered neuroplasticity in the brain and spinal cord and trains neural engineers from K-12 through graduate level.
- Ownership category
- akta.pro rank
Center for Neurotechnology industry classification
Industry- Product category
- Neural Engineering Research
- NAICS
- Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in Nanotechnology (541713)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Neurology/CNS Gene Therapies (HLAAACAH)
- akta.pro secondary industry
- Neurodiagnostic Centers (EEG/EMG/NCS) (HLAFAKAK)
Keywords
Where Center for Neurotechnology is headquartered
LocationHeadquarters
- HQ city
- Seattle
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
Center for Neurotechnology business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- NSF Engineering Research Center Funding: Primary funding from the National Science Foundation as one of several Engineering Research Centers across the country. This is the core operational funding for the center.
- Foundation Grants: Grants from foundations such as the Dana Foundation for specific programs like the Brain Health Learning Network.
- NSF Research Grants: Individual NSF grants awarded to CNT researchers for specific research projects, such as the three-year NSF grant to Amir Alimohammad for ubiquitous brain-computer interface research.
- Industry Memberships: The center has an Industry program with member benefits, suggesting industry partners pay membership fees for access to research and collaboration.
Go-to-market motion2 records
Distribution channels5 records
Marketing channels8 records
Center for Neurotechnology product offering
Product offeringCore offering
The Center for Neurotechnology (CNT) is an NSF Engineering Research Center that develops neural devices and methods for directing engineered neuroplasticity in the brain and spinal cord. Its work spans experimental and computational neuroscience, brain-computer interfaces, neurostimulation (including FDA-authorized transcutaneous spinal cord stimulation via ONWARD's ARC-EX), and neuroethics. CNT also operates structured education programs from K-12 through graduate level and runs an industry membership program for technology transfer.
Differentiator
Problem solved
Functional benefit
Products and services
- Young Scholars Program-REACH (YSP-REACH)
Quantifiable outcome
- FDA market authorization achieved for ARC-EX transcutaneous spinal cord stimulation system for spinal cord injury treatment
- +3 more outcomes
Companies that use Center for Neurotechnology
Customer profileNamed customers7 records
Segments5 records
Ideal customer profiles5 records
Center for Neurotechnology technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability9 records
Feature7 records
Center for Neurotechnology partnerships and signals
Strategic signalScale indicators5 records
Recent moves6 records
Expansion highlights6 records
Center for Neurotechnology competitors and assessment
Company assessmentDirect peers
- ONWARD Medical: ONWARD Medical commercialized the ARC-EX transcutaneous spinal cord stimulation system, which was developed through CNT research led by Chet Moritz. ONWARD directly extends CNT's neurostimulation research into commercial spinal cord injury therapies.
- Synchron: Synchron develops minimally invasive BCI technology for patients with paralysis. They are a peer in the brain-computer interface space, advancing clinical translation similar to CNT's BCI research and rehabilitation engineering focus.
- Neuralink: Neuralink develops implantable brain-computer interfaces, similar to CNT's BCI research and neural implant design toolbox. Both work on intracortical microstimulation and motor decoding, though Neuralink operates as a commercial entity with significant capital.
- Blackrock Neurotech: Blackrock Neurotech manufactures Utah-array based neural implants and BCI systems used in nonhuman primate and human research. Their neural implant technology overlaps with CNT's experimental neuroscience research thrust and neural implant design toolbox.
- Panaxium Research Inc. Panaxium Research licensed CNT neurostimulation technology for stroke and traumatic brain injury applications. They are a direct licensee and commercial partner extending CNT's neural engineering research into clinical applications.
- BrainGate Consortium: BrainGate is a multi-institution research consortium developing implantable BCI technology for people with paralysis. They overlap with CNT's brain-computer interface and neural engineering research, with a similar multi-university collaborative model.
Emerging players
- Paradromics: Paradromics is developing high-bandwidth brain-computer interfaces using microscale electrode arrays. They overlap with CNT's intracortical microstimulation and BCI research, though as a focused commercial startup.
- Precision Neuroscience: Precision Neuroscience develops cortical BCI technology for paralysis and neurological disorders. They compete in the same neural interface space as CNT's research, with commercial focus on minimally invasive electrode arrays.
Broad incumbents
- Massachusetts Institute of Technology (MIT) - Department of Materials Science and Engineering: MIT DMSE, headed by CNT deputy director Polina Anikeeva, conducts foundational neural engineering and bioelectronics research. As a core partner institution to CNT, MIT's DMSE shares research agenda and faculty overlap with CNT.
- Johns Hopkins Applied Physics Laboratory (Neurotechnology Group): Johns Hopkins APL has a major neurotechnology program developing brain-computer interfaces and neural prosthetics. They are a peer in the academic/government-affiliated neural engineering research space with overlapping BCI and neural stimulation research.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Center for Neurotechnology social profiles
Digital presenceCenter for Neurotechnology financial estimates
Financial estimateRevenue estimate
Valuation estimate
Center for Neurotechnology leadership team
Management profileNumber of profiles
Profiles7 records
Center for Neurotechnology funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Center for Neurotechnology M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Center for Neurotechnology
What does Center for Neurotechnology do?
The Center for Neurotechnology (CNT) is an NSF Engineering Research Center that develops neural devices and methods for directing engineered neuroplasticity in the brain and spinal cord. Its work spans experimental and computational neuroscience, brain-computer interfaces, neurostimulation (including FDA-authorized transcutaneous spinal cord stimulation via ONWARD's ARC-EX), and neuroethics. CNT also operates structured education programs from K-12 through graduate level and runs an industry membership program for technology transfer.
Is Center for Neurotechnology a public or private company?
Center for Neurotechnology is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Center for Neurotechnology founded?
Center for Neurotechnology was founded in 2011. It employs 51 to 100 people.
Where is Center for Neurotechnology based?
Center for Neurotechnology is headquartered in Seattle, United States, in the North America region.
How does Center for Neurotechnology make money?
Four revenue lines are on record. NSF Engineering Research Center Funding is the primary driver. The others are foundation Grants, NSF Research Grants and industry Memberships.
Who are Center for Neurotechnology's main competitors?
Direct peers on record are ONWARD Medical, Synchron, Neuralink, Blackrock Neurotech, Panaxium Research Inc. and BrainGate Consortium. Emerging players are Paradromics and Precision Neuroscience. Broad incumbents are Massachusetts Institute of Technology (MIT) - Department of Materials Science and Engineering and Johns Hopkins Applied Physics Laboratory (Neurotechnology Group).
Does Center for Neurotechnology have an API?
No public API is recorded for Center for Neurotechnology.
What industry is Center for Neurotechnology in?
Center for Neurotechnology's product category is Neural Engineering Research. Its primary akta.pro industry code is HLAAACAH, Neurology/CNS Gene Therapies, with a secondary code of HLAFAKAK, Neurodiagnostic Centers (EEG/EMG/NCS). Its NAICS code is 5417 and its SIC code is 3845.